<?xml version="1.0" encoding="UTF-8"?><MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="equilidem-basics"/>
  <meta>
    <security>
      <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
      <code value="HTEST"/>
      <display value="test health data"/>
    </security>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml">
			<p>
				<b>
					Generated Narrative
				</b>
			</p>
			<p>
				<b>
					Id
				</b>
				: equilidem-basics
			</p>
			<p>
				<b>
					Identifier
				</b>
				: Equilidem25
			</p>
			<p>
				<b>
					Combined Pharmaceutical Dose Form
				</b>
				:
				<span title="Codes: {http://example.org.uk/fhir/dosefom tablet}">
					tablet
				</span>
			</p>
			<p>
				<b>
					Indication
				</b>
				: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class &gt;= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
			</p>
			<p>
				<b>
					Legal Status Of Supply
				</b>
				:
				<span title="Codes: {http://example.org.uk/fhir/legalstatusofsupply POM}">
					Prescription only medicine
				</span>
			</p>
			<p>
				<b>
					Classification
				</b>
				:
				<span title="Codes: {http://www.whocc.no/atc/example B01A}">
					ATC: B01A
				</span>
			</p>
			<p>
				<b>
					Ingredient
				</b>
				:
			</p>
			<ul>
				<li>
					<span>
						Equilidonium Phosphate
					</span>
				</li>
				<li>
					<span>
						Calcium Carbonate
					</span>
				</li>
			</ul>
			<h3>
				Names
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Product Name
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						Equilidem 2.5 mg film-coated tablets
					</td>
				</tr>
			</table>
			<h3>
				Cross References
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Product
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						Link to generic equivalent
					</td>
				</tr>
			</table>
			<h3>
				Manufacturing/Business Operations
			</h3>
			<table class="grid">
				<tr>
					<td>
						-
					</td>
					<td>
						<b>
							Manufacturer
						</b>
					</td>
				</tr>
				<tr>
					<td>
						*
					</td>
					<td>
						<span>
							EquiliDrugCo Inc.
						</span>
					</td>
				</tr>
			</table>
		</div>
  </text>
  <identifier>
    <system value="http://example.org.uk/fhir/product"/>
    <value value="Equilidem25"/>
  </identifier>
  <combinedPharmaceuticalDoseForm>
    <coding>
      <system value="http://example.org.uk/fhir/dosefom"/>
      <code value="tablet"/>
    </coding>
  </combinedPharmaceuticalDoseForm>
  <indication value="Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class &gt;= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults."/>
  <legalStatusOfSupply>
    <coding>
      <system value="http://example.org.uk/fhir/legalstatusofsupply"/>
      <code value="POM"/>
      <display value="Prescription only medicine"/>
    </coding>
  </legalStatusOfSupply>
  <classification>
    <coding>
      <system value="http://www.whocc.no/atc/example"/>
      <code value="B01A"/>
    </coding>
  </classification>
  <ingredient>
    <text value="Equilidonium Phosphate"/>
  </ingredient>
  <ingredient>
    <text value="Calcium Carbonate"/>
  </ingredient>
  <name>
    <productName value="Equilidem 2.5 mg film-coated tablets"/>
  </name>
  <crossReference>
    <product>
      <reference>
        <reference value="MedicinalProductDefinition/genericEquilidonium"/>
      </reference>
    </product>
  </crossReference>
  <operation>
    <!--  licence holder would use RegulatedAuthorization  -->
    <organization>
      <display value="EquiliDrugCo Inc."/>
    </organization>
  </operation>
</MedicinalProductDefinition>